User login
A facial cutaneous horn
A healthy 84-year-old woman is referred to the dermatology department with a 10-month history of an asymptomatic lesion on her left cheek that has grown progressively. The lesion appeared spontaneously and was not associated with trauma.
On examination, there is a 2-cm-long, keratotic, gray cutaneous horn over a pink nodule on the left cheek (Figures 1 and 2). There is no lymphadenopathy, and the patient has no other cutaneous abnormalities.
The patient says she has had intense sunlight exposure during her life, due to agricultural work.
Q: What is the most likely diagnosis?
- Basal cell carcinoma
- Cutaneous leishmaniasis
- Squamous cell carcinoma
- Viral wart
- Pyoderma gangrenosum
A: Squamous cell carcinoma is the most likely diagnosis. It is the second most common form of skin cancer (after basal cell carcinoma) that arises on the sun-exposed skin of elderly individuals.
Basal cell carcinoma usually presents as a slow-growing, pearly nodule with telangiectasias over the surface, but without a keratotic component. Cutaneous leishmaniasis is caused by a protozoan and is transmitted by the bite of a sandfly. It presents as a crusted papule or ulcer at the site of the bite, only rarely presenting as a cutaneous horn. Viral warts may present as horns (filiform warts), but the horn is slender and is usually around the lips, eyelids, or nares. Although warts can occur at any age, they are more frequently seen among school-aged children, and they peak between ages 12 and 16. Pyoderma gangrenosum is considered a reactive dermatosis sometimes secondary to a systemic disease such as inflammatory bowel disease. It usually presents as a small, red papule or pustule that progresses to a larger ulcerative lesion.
SQUAMOUS CELL CARCINOMA: CAUSES, RISK FACTORS
Exposure to ultraviolet radiation is the most common cause of squamous cell carcinoma. Other risk factors include exposure to ionizing radiation, human papilloma virus, thermal injury, burns, immunosuppression, exposure to chemical carcinogens, and diseases such as xeroderma pigmentosum, oculocutaneous albinism, and junctional epidermolysis bullosa.1,2 Organ transplantation is another significant risk factor, and cutaneous squamous cell carcinoma is the most common malignancy in renal transplant recipients.3
People born in areas that receive high amounts of ultraviolet radiation from the sun have a risk of squamous cell carcinoma three times higher than people who move to those areas in adulthood.1 Occupational exposure to ultraviolet radiation is also implicated in this type of cancer.
CLINICAL APPEARANCE
Clinically, squamous cell carcinoma of the skin may manifest as a variety of primary morphologies with or without associated symptoms. The characteristic invasive squamous cell carcinoma is a raised, firm, pink or flesh-colored keratotic papule or plaque arising on sun-exposed skin. Approximately 70% of all squamous cell carcinomas occur on the head and neck, with an additional 15% found on the upper extremities. Surface changes may include scaling, ulceration, crusting, or the presence of a cutaneous horn. Squamous cell carcinoma can also present as an eczematous patch that does not resolve with emollient or topical steroids. Less commonly, it may manifest as a pink cutaneous nodule with no overlying surface changes. Often, the patient has a background of severely sun-damaged skin, including solar elastosis, mottled dyspigmentation, telangiectasia, and multiple actinic keratoses.
MAKING THE DIAGNOSIS
Skin biopsy usually confirms the clinical diagnosis. Histologic examination shows neoplastic proliferation of atypical keratinocytes extending into the dermis, with large hyperchromatic and pleomorphic nuclei.
Imaging is not routinely indicated for diagnosing cutaneous squamous cell carcinoma. However, radiologic imaging should be obtained in patients with regional lymphadenopathy or neurologic symptoms suggestive of perineural involvement.
Other lesions found at the base of a cutaneous horn include actinic keratosis, keratoacanthoma, basal cell carcinoma, and benign lesions such as seborrheic keratosis and verruca vulgaris.4,5
MANAGEMENT
Most cutaneous squamous cell carcinomas are easily treated, and the rate of cure is high. Treatment options include topical chemotherapy, cryosurgery, electrodesiccation and curettage, surgical excision, Mohs micrographic surgery, radiotherapy, and photodynamic therapy. Fractionated radiation treatment may be preferred for patients who are unable to tolerate surgery or who have inoperable tumors, and it may provide favorable functional and cosmetic results.1
Photodynamic therapy and topical chemotherapy with imiquimod are currently not recommended for invasive squamous cell carcinoma.
Low-risk tumors are usually cured with surgical therapy. However, patients who develop one squamous cell carcinoma have a 40% risk of developing additional squamous cell carcinomas within the next 2 years. This risk is likely even greater as more time elapses. Thus, patients with a history of this cancer should be evaluated with a complete skin examination every 6 to 12 months.
OUR PATIENT’S TREATMENT
Our patient underwent total surgical excision of the lesion with a safety margin of 0.5 cm. Histologic results confirmed the diagnosis of squamous cell carcinoma with tumor-free margins. No clinical relapse was observed after 1 year of follow-up.
- Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975–983.
- Mallipeddi R, Keane FM, Mcgrath JA, Mayou BJ, Eady RA. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa. J Eur Acad Dermatol Venereol 2004; 18:521–526.
- Rubel JR, Milford EL, Abdi R. Cutaneous neoplasms in renal transplant recipients. Eur J Dermatol 2002; 12:532–535.
- Aydogan K, Ozbek S, Balaban Adim S, Tokgöz N. Irritated seborrhoeic keratosis presenting as a cutaneous horn. J Eur Acad Dermatol Venereol 2006; 20:626–628.
- Vañó-Galván S, Sanchez-Olaso A. Images in clinical medicine. Squamous-cell carcinoma manifesting as a cutaneous horn. N Engl J Med 2008; 359:e10.
A healthy 84-year-old woman is referred to the dermatology department with a 10-month history of an asymptomatic lesion on her left cheek that has grown progressively. The lesion appeared spontaneously and was not associated with trauma.
On examination, there is a 2-cm-long, keratotic, gray cutaneous horn over a pink nodule on the left cheek (Figures 1 and 2). There is no lymphadenopathy, and the patient has no other cutaneous abnormalities.
The patient says she has had intense sunlight exposure during her life, due to agricultural work.
Q: What is the most likely diagnosis?
- Basal cell carcinoma
- Cutaneous leishmaniasis
- Squamous cell carcinoma
- Viral wart
- Pyoderma gangrenosum
A: Squamous cell carcinoma is the most likely diagnosis. It is the second most common form of skin cancer (after basal cell carcinoma) that arises on the sun-exposed skin of elderly individuals.
Basal cell carcinoma usually presents as a slow-growing, pearly nodule with telangiectasias over the surface, but without a keratotic component. Cutaneous leishmaniasis is caused by a protozoan and is transmitted by the bite of a sandfly. It presents as a crusted papule or ulcer at the site of the bite, only rarely presenting as a cutaneous horn. Viral warts may present as horns (filiform warts), but the horn is slender and is usually around the lips, eyelids, or nares. Although warts can occur at any age, they are more frequently seen among school-aged children, and they peak between ages 12 and 16. Pyoderma gangrenosum is considered a reactive dermatosis sometimes secondary to a systemic disease such as inflammatory bowel disease. It usually presents as a small, red papule or pustule that progresses to a larger ulcerative lesion.
SQUAMOUS CELL CARCINOMA: CAUSES, RISK FACTORS
Exposure to ultraviolet radiation is the most common cause of squamous cell carcinoma. Other risk factors include exposure to ionizing radiation, human papilloma virus, thermal injury, burns, immunosuppression, exposure to chemical carcinogens, and diseases such as xeroderma pigmentosum, oculocutaneous albinism, and junctional epidermolysis bullosa.1,2 Organ transplantation is another significant risk factor, and cutaneous squamous cell carcinoma is the most common malignancy in renal transplant recipients.3
People born in areas that receive high amounts of ultraviolet radiation from the sun have a risk of squamous cell carcinoma three times higher than people who move to those areas in adulthood.1 Occupational exposure to ultraviolet radiation is also implicated in this type of cancer.
CLINICAL APPEARANCE
Clinically, squamous cell carcinoma of the skin may manifest as a variety of primary morphologies with or without associated symptoms. The characteristic invasive squamous cell carcinoma is a raised, firm, pink or flesh-colored keratotic papule or plaque arising on sun-exposed skin. Approximately 70% of all squamous cell carcinomas occur on the head and neck, with an additional 15% found on the upper extremities. Surface changes may include scaling, ulceration, crusting, or the presence of a cutaneous horn. Squamous cell carcinoma can also present as an eczematous patch that does not resolve with emollient or topical steroids. Less commonly, it may manifest as a pink cutaneous nodule with no overlying surface changes. Often, the patient has a background of severely sun-damaged skin, including solar elastosis, mottled dyspigmentation, telangiectasia, and multiple actinic keratoses.
MAKING THE DIAGNOSIS
Skin biopsy usually confirms the clinical diagnosis. Histologic examination shows neoplastic proliferation of atypical keratinocytes extending into the dermis, with large hyperchromatic and pleomorphic nuclei.
Imaging is not routinely indicated for diagnosing cutaneous squamous cell carcinoma. However, radiologic imaging should be obtained in patients with regional lymphadenopathy or neurologic symptoms suggestive of perineural involvement.
Other lesions found at the base of a cutaneous horn include actinic keratosis, keratoacanthoma, basal cell carcinoma, and benign lesions such as seborrheic keratosis and verruca vulgaris.4,5
MANAGEMENT
Most cutaneous squamous cell carcinomas are easily treated, and the rate of cure is high. Treatment options include topical chemotherapy, cryosurgery, electrodesiccation and curettage, surgical excision, Mohs micrographic surgery, radiotherapy, and photodynamic therapy. Fractionated radiation treatment may be preferred for patients who are unable to tolerate surgery or who have inoperable tumors, and it may provide favorable functional and cosmetic results.1
Photodynamic therapy and topical chemotherapy with imiquimod are currently not recommended for invasive squamous cell carcinoma.
Low-risk tumors are usually cured with surgical therapy. However, patients who develop one squamous cell carcinoma have a 40% risk of developing additional squamous cell carcinomas within the next 2 years. This risk is likely even greater as more time elapses. Thus, patients with a history of this cancer should be evaluated with a complete skin examination every 6 to 12 months.
OUR PATIENT’S TREATMENT
Our patient underwent total surgical excision of the lesion with a safety margin of 0.5 cm. Histologic results confirmed the diagnosis of squamous cell carcinoma with tumor-free margins. No clinical relapse was observed after 1 year of follow-up.
A healthy 84-year-old woman is referred to the dermatology department with a 10-month history of an asymptomatic lesion on her left cheek that has grown progressively. The lesion appeared spontaneously and was not associated with trauma.
On examination, there is a 2-cm-long, keratotic, gray cutaneous horn over a pink nodule on the left cheek (Figures 1 and 2). There is no lymphadenopathy, and the patient has no other cutaneous abnormalities.
The patient says she has had intense sunlight exposure during her life, due to agricultural work.
Q: What is the most likely diagnosis?
- Basal cell carcinoma
- Cutaneous leishmaniasis
- Squamous cell carcinoma
- Viral wart
- Pyoderma gangrenosum
A: Squamous cell carcinoma is the most likely diagnosis. It is the second most common form of skin cancer (after basal cell carcinoma) that arises on the sun-exposed skin of elderly individuals.
Basal cell carcinoma usually presents as a slow-growing, pearly nodule with telangiectasias over the surface, but without a keratotic component. Cutaneous leishmaniasis is caused by a protozoan and is transmitted by the bite of a sandfly. It presents as a crusted papule or ulcer at the site of the bite, only rarely presenting as a cutaneous horn. Viral warts may present as horns (filiform warts), but the horn is slender and is usually around the lips, eyelids, or nares. Although warts can occur at any age, they are more frequently seen among school-aged children, and they peak between ages 12 and 16. Pyoderma gangrenosum is considered a reactive dermatosis sometimes secondary to a systemic disease such as inflammatory bowel disease. It usually presents as a small, red papule or pustule that progresses to a larger ulcerative lesion.
SQUAMOUS CELL CARCINOMA: CAUSES, RISK FACTORS
Exposure to ultraviolet radiation is the most common cause of squamous cell carcinoma. Other risk factors include exposure to ionizing radiation, human papilloma virus, thermal injury, burns, immunosuppression, exposure to chemical carcinogens, and diseases such as xeroderma pigmentosum, oculocutaneous albinism, and junctional epidermolysis bullosa.1,2 Organ transplantation is another significant risk factor, and cutaneous squamous cell carcinoma is the most common malignancy in renal transplant recipients.3
People born in areas that receive high amounts of ultraviolet radiation from the sun have a risk of squamous cell carcinoma three times higher than people who move to those areas in adulthood.1 Occupational exposure to ultraviolet radiation is also implicated in this type of cancer.
CLINICAL APPEARANCE
Clinically, squamous cell carcinoma of the skin may manifest as a variety of primary morphologies with or without associated symptoms. The characteristic invasive squamous cell carcinoma is a raised, firm, pink or flesh-colored keratotic papule or plaque arising on sun-exposed skin. Approximately 70% of all squamous cell carcinomas occur on the head and neck, with an additional 15% found on the upper extremities. Surface changes may include scaling, ulceration, crusting, or the presence of a cutaneous horn. Squamous cell carcinoma can also present as an eczematous patch that does not resolve with emollient or topical steroids. Less commonly, it may manifest as a pink cutaneous nodule with no overlying surface changes. Often, the patient has a background of severely sun-damaged skin, including solar elastosis, mottled dyspigmentation, telangiectasia, and multiple actinic keratoses.
MAKING THE DIAGNOSIS
Skin biopsy usually confirms the clinical diagnosis. Histologic examination shows neoplastic proliferation of atypical keratinocytes extending into the dermis, with large hyperchromatic and pleomorphic nuclei.
Imaging is not routinely indicated for diagnosing cutaneous squamous cell carcinoma. However, radiologic imaging should be obtained in patients with regional lymphadenopathy or neurologic symptoms suggestive of perineural involvement.
Other lesions found at the base of a cutaneous horn include actinic keratosis, keratoacanthoma, basal cell carcinoma, and benign lesions such as seborrheic keratosis and verruca vulgaris.4,5
MANAGEMENT
Most cutaneous squamous cell carcinomas are easily treated, and the rate of cure is high. Treatment options include topical chemotherapy, cryosurgery, electrodesiccation and curettage, surgical excision, Mohs micrographic surgery, radiotherapy, and photodynamic therapy. Fractionated radiation treatment may be preferred for patients who are unable to tolerate surgery or who have inoperable tumors, and it may provide favorable functional and cosmetic results.1
Photodynamic therapy and topical chemotherapy with imiquimod are currently not recommended for invasive squamous cell carcinoma.
Low-risk tumors are usually cured with surgical therapy. However, patients who develop one squamous cell carcinoma have a 40% risk of developing additional squamous cell carcinomas within the next 2 years. This risk is likely even greater as more time elapses. Thus, patients with a history of this cancer should be evaluated with a complete skin examination every 6 to 12 months.
OUR PATIENT’S TREATMENT
Our patient underwent total surgical excision of the lesion with a safety margin of 0.5 cm. Histologic results confirmed the diagnosis of squamous cell carcinoma with tumor-free margins. No clinical relapse was observed after 1 year of follow-up.
- Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975–983.
- Mallipeddi R, Keane FM, Mcgrath JA, Mayou BJ, Eady RA. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa. J Eur Acad Dermatol Venereol 2004; 18:521–526.
- Rubel JR, Milford EL, Abdi R. Cutaneous neoplasms in renal transplant recipients. Eur J Dermatol 2002; 12:532–535.
- Aydogan K, Ozbek S, Balaban Adim S, Tokgöz N. Irritated seborrhoeic keratosis presenting as a cutaneous horn. J Eur Acad Dermatol Venereol 2006; 20:626–628.
- Vañó-Galván S, Sanchez-Olaso A. Images in clinical medicine. Squamous-cell carcinoma manifesting as a cutaneous horn. N Engl J Med 2008; 359:e10.
- Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975–983.
- Mallipeddi R, Keane FM, Mcgrath JA, Mayou BJ, Eady RA. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa. J Eur Acad Dermatol Venereol 2004; 18:521–526.
- Rubel JR, Milford EL, Abdi R. Cutaneous neoplasms in renal transplant recipients. Eur J Dermatol 2002; 12:532–535.
- Aydogan K, Ozbek S, Balaban Adim S, Tokgöz N. Irritated seborrhoeic keratosis presenting as a cutaneous horn. J Eur Acad Dermatol Venereol 2006; 20:626–628.
- Vañó-Galván S, Sanchez-Olaso A. Images in clinical medicine. Squamous-cell carcinoma manifesting as a cutaneous horn. N Engl J Med 2008; 359:e10.
Acute facial purpura in an 82-year-old woman with a respiratory tract infection
An 82-year-old woman presents with facial purpuric lesions that developed while she was hospitalized for an acute respiratory tract infection characterized by severe paroxysms of nonproductive cough and dyspnea. The lesions appeared suddenly and spontaneously and were not associated with trauma. The patient denies pruritus or pain and is otherwise well. The remainder of her physical examination is within normal limits. She has hypertension, diabetes, and hyperuricemia but has had no recent changes in her medications.
Q: What is the most likely diagnosis?
- Amyloidosis
- Idiopathic thrombocytopenic purpura
- “Cough purpura”
- Purpura fulminans
- Actinic purpura
A: The correct answer is cough purpura, a benign and nonthrombocytopenic eruption that appears to be related to a sudden rise in the venous and capillary pressure in the head and neck caused by a rise in intrathoracic pressure during coughing.1–3 Physical examination shows erythematous, nonblanching macules, smaller than 1 cm, distributed on the face and neck.
Cough purpura is one form of the “mask phenomenon,”4 which is an unusual purpura of the relatively loose tissues of the face and neck occurring after vigorous vomiting, the Valsalva maneuver, parturition, prolonged coughing, or any other exertion that raises intrathoracic or abdominal pressure.1–5 The onset is acute. A workup for a coagulation or platelet defect is usually not required. Facial localization is unusual in most other forms of purpura, so its presence in addition to coughing should suggest cough purpura.
Recognizing cough purpura can help avoid misdiagnoses such thrombocytopenic purpura or purpura fulminans that could lead to ordering unnecessary tests, frightening the patient, and unnecessary confusion. The purpura fades spontaneously within 24 to 72 hours, and no treatment is needed.
- Kravitz P. The clinical picture of “cough purpura,” benign and non-thrombocytopenic eruption. Va Med 1979; 106:373–374.
- Pierson JC, Suh PS. Powerlifter’s purpura: a Valsalva-associated phenomenon. Cutis 2002; 70:93–94.
- Santiago Sánchez-Mateos JL, Aldanondo Fernández de la Mora I, Harto Castaño A, Jaén Olasolo P. Facial-cervical purpura. Rev Clin Esp 2007; 207:530–532.
- Alcalay J, Ingber A, Sandbank M. Mask phenomenon: postemesis facial purpura. Cutis 1986; 38:28.
- Wilkin JK. Benign parturient purpura. JAMA 1978; 239:930.
An 82-year-old woman presents with facial purpuric lesions that developed while she was hospitalized for an acute respiratory tract infection characterized by severe paroxysms of nonproductive cough and dyspnea. The lesions appeared suddenly and spontaneously and were not associated with trauma. The patient denies pruritus or pain and is otherwise well. The remainder of her physical examination is within normal limits. She has hypertension, diabetes, and hyperuricemia but has had no recent changes in her medications.
Q: What is the most likely diagnosis?
- Amyloidosis
- Idiopathic thrombocytopenic purpura
- “Cough purpura”
- Purpura fulminans
- Actinic purpura
A: The correct answer is cough purpura, a benign and nonthrombocytopenic eruption that appears to be related to a sudden rise in the venous and capillary pressure in the head and neck caused by a rise in intrathoracic pressure during coughing.1–3 Physical examination shows erythematous, nonblanching macules, smaller than 1 cm, distributed on the face and neck.
Cough purpura is one form of the “mask phenomenon,”4 which is an unusual purpura of the relatively loose tissues of the face and neck occurring after vigorous vomiting, the Valsalva maneuver, parturition, prolonged coughing, or any other exertion that raises intrathoracic or abdominal pressure.1–5 The onset is acute. A workup for a coagulation or platelet defect is usually not required. Facial localization is unusual in most other forms of purpura, so its presence in addition to coughing should suggest cough purpura.
Recognizing cough purpura can help avoid misdiagnoses such thrombocytopenic purpura or purpura fulminans that could lead to ordering unnecessary tests, frightening the patient, and unnecessary confusion. The purpura fades spontaneously within 24 to 72 hours, and no treatment is needed.
An 82-year-old woman presents with facial purpuric lesions that developed while she was hospitalized for an acute respiratory tract infection characterized by severe paroxysms of nonproductive cough and dyspnea. The lesions appeared suddenly and spontaneously and were not associated with trauma. The patient denies pruritus or pain and is otherwise well. The remainder of her physical examination is within normal limits. She has hypertension, diabetes, and hyperuricemia but has had no recent changes in her medications.
Q: What is the most likely diagnosis?
- Amyloidosis
- Idiopathic thrombocytopenic purpura
- “Cough purpura”
- Purpura fulminans
- Actinic purpura
A: The correct answer is cough purpura, a benign and nonthrombocytopenic eruption that appears to be related to a sudden rise in the venous and capillary pressure in the head and neck caused by a rise in intrathoracic pressure during coughing.1–3 Physical examination shows erythematous, nonblanching macules, smaller than 1 cm, distributed on the face and neck.
Cough purpura is one form of the “mask phenomenon,”4 which is an unusual purpura of the relatively loose tissues of the face and neck occurring after vigorous vomiting, the Valsalva maneuver, parturition, prolonged coughing, or any other exertion that raises intrathoracic or abdominal pressure.1–5 The onset is acute. A workup for a coagulation or platelet defect is usually not required. Facial localization is unusual in most other forms of purpura, so its presence in addition to coughing should suggest cough purpura.
Recognizing cough purpura can help avoid misdiagnoses such thrombocytopenic purpura or purpura fulminans that could lead to ordering unnecessary tests, frightening the patient, and unnecessary confusion. The purpura fades spontaneously within 24 to 72 hours, and no treatment is needed.
- Kravitz P. The clinical picture of “cough purpura,” benign and non-thrombocytopenic eruption. Va Med 1979; 106:373–374.
- Pierson JC, Suh PS. Powerlifter’s purpura: a Valsalva-associated phenomenon. Cutis 2002; 70:93–94.
- Santiago Sánchez-Mateos JL, Aldanondo Fernández de la Mora I, Harto Castaño A, Jaén Olasolo P. Facial-cervical purpura. Rev Clin Esp 2007; 207:530–532.
- Alcalay J, Ingber A, Sandbank M. Mask phenomenon: postemesis facial purpura. Cutis 1986; 38:28.
- Wilkin JK. Benign parturient purpura. JAMA 1978; 239:930.
- Kravitz P. The clinical picture of “cough purpura,” benign and non-thrombocytopenic eruption. Va Med 1979; 106:373–374.
- Pierson JC, Suh PS. Powerlifter’s purpura: a Valsalva-associated phenomenon. Cutis 2002; 70:93–94.
- Santiago Sánchez-Mateos JL, Aldanondo Fernández de la Mora I, Harto Castaño A, Jaén Olasolo P. Facial-cervical purpura. Rev Clin Esp 2007; 207:530–532.
- Alcalay J, Ingber A, Sandbank M. Mask phenomenon: postemesis facial purpura. Cutis 1986; 38:28.
- Wilkin JK. Benign parturient purpura. JAMA 1978; 239:930.